Skip to main content
. Author manuscript; available in PMC: 2017 May 1.
Published in final edited form as: Gynecol Oncol. 2016 Mar 11;141(2):348–356. doi: 10.1016/j.ygyno.2016.02.030

Figure 3. NR4A1 immunohistochemical staining in benign and malignant ovarian tissue.

Figure 3

Figure 3A is a table outlining histology of patient ovarian cancer samples analyzed and localization of NR4A1 staining. Positive NR4A1 staining was determined by observing at least 10% of cells in a given field with brown staining in the nucleus or cytoplasm respectively. Figure 3B shows representative images of immunohistochemical H&E and NR4A1 staining. Representative images are shown with 20x magnification and 40x insets.